Massachusetts General Hospital Cancer Center

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Massachusetts General Hospital Cancer Center

https://www.massgeneral.org/cancer-center

Changing Updates in Hematologic Malignancies
Grand Rounds
Videos
Events

Playback speed

10 seconds

Next Steps in FGFRi in Cholangiocarcinoma: FGFR Pathway & Current Landscape of Inhibitors, Drug Failure, and Pipeline of Next Generation of Trials

By Massachusetts General Hospital Cancer Center FEATURING Lipika Goyal

238 views

August 4, 2021

Comments 0

Videos

New

Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia:…

Massachusetts General Hospital Cancer Center

H. Al-Samkari

Understanding ESR1 Mutations in HR+/HER2- mBC: Testing Methods, Pati…

Massachusetts General Hospital Cancer Center

S. Wander

316 views

Uveal Melanoma for Community Oncologists

Massachusetts General Hospital Cancer Center

K. Montazeri

113 views

2023 SMR Congress Insights: "Time-to-Event Machine Learning Predicti…

Insights from 2023 Society for Melanoma Research Annual Meeting

Y. Semenov

59 views

SOHO 2023: CAR/BsAb Toxicity in MM - Prevention, Treatment, and Surv…

SOHO 2023 Eleventh Annual Meeting

N. S. Raje

161 views

Updated Data for Ziftomenib in Adults With NPM1-Mutated R/R AML

Insights from 2023 EHA® Annual Meeting

A. Fathi

241 views

ASCO® 2023 Insights: "Phase 1/2 TRIDENT-1 Trial - Intracranial and S…

Insights from 2023 ASCO® Annual Meeting

J. Lin

86 views

ESR1 Mutations in HR+/HER2- mBC and Their Role in Treatment Outcomes

Massachusetts General Hospital Cancer Center

S. Wander

250 views

Genetic Heterogeneity in Brain Metastases and Implications for Clini…

Massachusetts General Hospital Cancer Center

P. Brastianos

15 views

Maintenance Therapy in AML: Protecting Remission, Extending Survival…

Massachusetts General Hospital Cancer Center

A. Brunner

219 views

ESMO 2021 Updates on 1L DKN-01 + Tislelizumab & Chemotherapy in Adva…

Massachusetts General Hospital Cancer Center

S. Klempner

108 views

Selpercatinib Efficacy & Safety in Patients With RET-Altered Thyroid…

Massachusetts General Hospital Cancer Center

L. Wirth

42 views

10:05

i3 Health

Emerging Treatment Strategies for Advanced Cholangiocarcinoma: Molec…

Feat. L. Goyal

Next Steps in FGFRi in Cholangiocarcinoma: FGFR Pathway & Current La…

Massachusetts General Hospital Cancer Center

L. Goyal

238 views

ASCO 2021 Highlights From GEOMETRY mono-1 Study on Advanced NSCLC: C…

Massachusetts General Hospital Cancer Center

R. Heist

40 views

2021 Updates on mTNBC: Do Olaparib/Talazoparib Improve PFS Compared …

Virtual West Oncology Conference

N. Vidula

72 views

Targeted Therapy for EGFR+ NSCLC: What Are the Current Options Upon …

GRACE

Z. Piotrowska

104 views

Targeted Therapy for EGFR+ NSCLC: How Do We Think About Acquired Res…

GRACE

Z. Piotrowska

114 views

Tumor Infiltrating Lymphocytes: What Is the Data That Supports the P…

Massachusetts General Hospital Cancer Center

K. Flaherty

16 views

Targeting Exon 20 Insertions in NSCLC: Anti-Tumor Activity With T-Dx…

2020 ASCO Virtual Direct™ Highlights

I. Dagogo-Jack

327 views

2020 ESMO Update on Targeted Therapy in NSCLC: Can We Safely Combine…

2020 Virtual ESMO Review

I. Dagogo-Jack

29 views

2020 ESMO Update on Targeted Therapy in NSCLC: Does ADAURA Trial Sug…

2020 Virtual ESMO Review

I. Dagogo-Jack

177 views

2020 ESMO Update on ADCs in mTNBC: Is Sacituzumab Govitecan More Ben…

ecancer

A. Bardia

273 views

13:34

2020 Virtual ESMO Review

2020 ESMO Update on Targeted Therapy in NSCLC: Can We Safely Combine…

Feat. I. Dagogo-Jack

Risk Factors in Lung Cancer: Which Risk Factor Is Predominant? How I…

Virtual Diversity in Cancer Care

I. Dagogo-Jack

157 views